Fintel reports that on January 30, 2025, William Blair downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from ...
Equities researchers at William Blair issued their FY2025 EPS estimates for VSE in a research note issued on Monday, January 27th. William Blair analyst L. Dipalma anticipates that the construction ...
Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.
Stock analysts at William Blair dropped their Q1 2025 earnings per share estimates for GE Vernova in a research report issued ...
American Express beat expectations for fourth-quarter revenue on Friday, as more consumers swiped its cards during the ...
William Blair downgraded Charles River (CRL) to Market Perform from Outperform without a price target “There is simply too much working against Charles River in the near term to make the stock ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 2.08% of ...